This is the case with tumors like the clear cell renal cell carcinoma (ccRCC) and the CRC in which the reactivation of the p53 pathway could be one of the best treatment strategies [250,251,252]. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.